Semaglutide's gastric-emptying delay is additive to pre-existing gastroparesis, and the Wegovy label [5] notes it has not been studied in patients with severe gastroparesis
Variables assessed include weight loss, dietary factors, and metformin exposure, all of which may independently influence gut microbiota composition and function
The most successful and sustainable weight loss happens when medication is paired with lifestyle modifications in diet, exercise, and behavior
I can take my ACE without an issue
Contrave : Combines naltrexone and bupropion to target brain areas controlling hunger and cravings
Semaglutide may not be safe for people who have had medullary thyroid cancer, multiple endocrine neoplasia type 2 (MEN 2), or pancreatitis